cardiovascular risk
08/14/2018 / By Zoey Sky
New study on aspirin has contradictory results, finding both increased and decreased risks for use in diabetic patients
Based on research that was presented at the American College of Cardiology‘s 67th Annual Scientific Session, individuals who have both Type 2 diabetes and heart failure, and take an aspirin daily, seem to have a lower risk of dying or being hospitalized for heart failure. But surprisingly enough, the data showed that the intake of aspirin […]
1 of 1

Popular Articles

PharmaceuticalFraud.com is a fact-based public education website published by Pharmaceutical Fraud Features, LLC.

All content copyright © 2018 by Pharmaceutical Fraud Features, LLC.

Contact Us with Tips or Corrections

All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.

Privacy Policy